BIOMAT Database Logo BIOMAT Database Logo

Synthesis of isomeric 3-piperidinyl and 3-pyrrolidinyl benzo[5,6]cyclohepta[1,2-b]pyridines: sulfonamido derivatives as inhibitors of Ras prenylation. 1998

J Kelly, and R Wolin, and M Connolly, and A Afonso, and L James, and P Kirshmeier, and W R Bishop, and A T McPhail
Schering-Plough Research Institute, Kenilworth, NJ 07033, USA.

Blocking farnesylation of oncogenic Ras proteins is a mechanism based therapeutic approach that is of current interest for the development of antitumor agents to treat ras associated tumors. As part of a SAR study on the lead farnesyl protein transferase (FPT) inhibitor I, we report here the synthesis of novel geometric isomers II and III and the FPT inhibition activity of their N-acyl and N-sulfonamido derivatives 15-65. The N-acyl derivatives are markedly less active than the lead inhibitor I thereby demonstrating that the spatial location of the N-acyl group in I is critical for binding of the compound to FPT. In contrast to I, the N-sulfonamido-II series is a novel lead of non-sulfhydryl, nonpeptidic compounds that are dual FPT/GGPT inhibitors. In light of recent reports on the alternative prenylation of N- and K-Ras, dual FPT/GGPT inhibitors may be required to control cell proliferation in tumors containing activated Ras.

UI MeSH Term Description Entries
D010880 Piperidines A family of hexahydropyridines.
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D016283 Proto-Oncogene Proteins p21(ras) Cellular proteins encoded by the H-ras, K-ras and N-ras genes. The proteins have GTPase activity and are involved in signal transduction as monomeric GTP-binding proteins. Elevated levels of p21 c-ras have been associated with neoplasia. This enzyme was formerly listed as EC 3.6.1.47. Proto-Oncogene Proteins c-ras,c-Ha-ras p21,c-Ki-ras p21,p21(N-ras),p21(c-Ha-ras),p21(c-Ki-ras),p21(c-ras),p21(ras),ras Proto-Oncogene Protein p21,Proto-Oncogene Protein p21(c-Ha-ras),Proto-Oncogene Protein p21(c-Ki-ras),Proto-Oncogene Protein p21(c-N-ras),Proto-Oncogene Protein p21(ras),Proto-Oncogene Protein ras,c-ras Proteins,p21 c-H-ras,p21 c-Ha-ras,p21 c-K-ras,p21 c-Ki-ras,p21 c-ras,ras Proto-Oncogene Product p21,Proteins c-ras, Proto-Oncogene,Proto Oncogene Protein ras,Proto Oncogene Proteins c ras,c Ha ras p21,c Ki ras p21,c ras Proteins,c-H-ras, p21,c-Ha-ras, p21,c-K-ras, p21,c-Ki-ras, p21,c-ras, Proto-Oncogene Proteins,c-ras, p21,p21 c H ras,p21 c Ha ras,p21 c K ras,p21 c Ki ras,p21 c ras,p21, c-Ha-ras,p21, c-Ki-ras,ras Proto Oncogene Product p21,ras Proto Oncogene Protein p21,ras, Proto-Oncogene Protein
D017368 Protein Prenylation A post-translational modification of proteins by the attachment of an isoprenoid to the C-terminal cysteine residue. The isoprenoids used, farnesyl diphosphate or geranylgeranyl diphosphate, are derived from the same biochemical pathway that produces cholesterol. Post-Translational Isoprenylation,Protein Isoprenylation,Protein Farnesylation,Protein Geranylgeranylation,Protein Polyisoprenylation,Farnesylation, Protein,Geranylgeranylation, Protein,Polyisoprenylation, Protein,Prenylation, Protein
D019883 Alkyl and Aryl Transferases A somewhat heterogeneous class of enzymes that catalyze the transfer of alkyl or related groups (excluding methyl groups). EC 2.5. Alkyltransferase,Alkyltransferases,Aryltransferase,Aryltransferases

Related Publications

J Kelly, and R Wolin, and M Connolly, and A Afonso, and L James, and P Kirshmeier, and W R Bishop, and A T McPhail
Synthesis of 5,6-dihydro-11H-benzo[5,6]-cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidine-N-cyanoguanidine derivatives as inhibitors of ras farnesyl protein transferase.
February 2002, Bioorganic & medicinal chemistry letters,
J Kelly, and R Wolin, and M Connolly, and A Afonso, and L James, and P Kirshmeier, and W R Bishop, and A T McPhail
Synthesis and pharmacological properties of some derivatives of 5H-benzo (4,5) cyclohepta (1,2-b) pyridine nd of 11H-benzo (5,6) cyclohepta (1,2-c) pyridine. 3.
January 1972, Arzneimittel-Forschung,
J Kelly, and R Wolin, and M Connolly, and A Afonso, and L James, and P Kirshmeier, and W R Bishop, and A T McPhail
N-substituted 11-(4-piperidylene)-5,6-dihydro-11H-benzo-[5,6]cyclohepta [1,2-b]pyridines. Antihistamines with no sedating liability.
September 1986, Arzneimittel-Forschung,
J Kelly, and R Wolin, and M Connolly, and A Afonso, and L James, and P Kirshmeier, and W R Bishop, and A T McPhail
Design and synthesis of thiourea derivatives containing a benzo[5,6]cyclohepta[1,2-b]pyridine moiety as potential antitumor and anti-inflammatory agents.
April 2012, Bioorganic & medicinal chemistry letters,
J Kelly, and R Wolin, and M Connolly, and A Afonso, and L James, and P Kirshmeier, and W R Bishop, and A T McPhail
Reaction of dichloroketene and sulfene with N,N-disubstituted 6-aminomethylene-5,6,8,9-tetrahydro-7H-benzocyclohepten-7-ones. Synthesis of 5H-benzo(5,6)cyclohepta(2,1-b)pyran and 5H-benzo(5,6)cyclohepta(1,2-e)-1,2-oxathiin derivatives.
November 1977, Il Farmaco; edizione scientifica,
J Kelly, and R Wolin, and M Connolly, and A Afonso, and L James, and P Kirshmeier, and W R Bishop, and A T McPhail
Synthesis and pharmacological properties of some 5H-benzo(4,5)cyclohepta(1,2-b)pyridine derivatives.
June 1968, Arzneimittel-Forschung,
J Kelly, and R Wolin, and M Connolly, and A Afonso, and L James, and P Kirshmeier, and W R Bishop, and A T McPhail
Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine.
March 1998, Journal of medicinal chemistry,
J Kelly, and R Wolin, and M Connolly, and A Afonso, and L James, and P Kirshmeier, and W R Bishop, and A T McPhail
Synthesis and pharmacological properties of some derivatives of 5H-benzo(4,5)cyclohepta(1,2-b)pyridine. II.
September 1971, Arzneimittel-Forschung,
J Kelly, and R Wolin, and M Connolly, and A Afonso, and L James, and P Kirshmeier, and W R Bishop, and A T McPhail
Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives.
October 2017, Chemical biology & drug design,
J Kelly, and R Wolin, and M Connolly, and A Afonso, and L James, and P Kirshmeier, and W R Bishop, and A T McPhail
Benzo[6,7]cyclohepta[1,2-b]pyran derivatives with platelet antiaggregating and other activities.
March 1991, Farmaco (Societa chimica italiana : 1989),
Copied contents to your clipboard!